| Antimonene quantum dots: synthesis and application as near‐infrared photothermal agents for effective cancer therapy W Tao, X Ji, X Xu, MA Islam, Z Li, S Chen, PE Saw, H Zhang, Z Bharwani, ... Angewandte Chemie International Edition 56 (39), 11896-11900, 2017 | 523 | 2017 |
| ROS‐responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy X Xu, PE Saw, W Tao, Y Li, X Ji, S Bhasin, Y Liu, D Ayyash, J Rasmussen, ... Advanced materials 29 (33), 1700141, 2017 | 418 | 2017 |
| Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output Q Zhao, J Liu, H Deng, R Ma, JY Liao, H Liang, J Hu, J Li, Z Guo, J Cai, ... Cell 183 (1), 76-93. e22, 2020 | 264 | 2020 |
| Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles YJ Cheng, GF Luo, JY Zhu, XD Xu, X Zeng, DB Cheng, YM Li, Y Wu, ... ACS applied materials & interfaces 7 (17), 9078-9087, 2015 | 241 | 2015 |
| Ultra‐pH‐responsive and tumor‐penetrating nanoplatform for targeted siRNA delivery with robust anti‐cancer efficacy X Xu, J Wu, Y Liu, M Yu, L Zhao, X Zhu, S Bhasin, Q Li, E Ha, J Shi, ... Angewandte Chemie International Edition 55 (25), 7091-7094, 2016 | 235 | 2016 |
| Hydrophobic cysteine poly (disulfide)‐based redox‐hypersensitive nanoparticle platform for cancer theranostics J Wu, L Zhao, X Xu, N Bertrand, WII Choi, B Yameen, J Shi, V Shah, ... Angewandte Chemie 127 (32), 9350-9355, 2015 | 204 | 2015 |
| Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy X Zhu, X Ji, N Kong, Y Chen, M Mahmoudi, X Xu, L Ding, W Tao, T Cai, ... ACS nano 12 (3), 2922-2938, 2018 | 191 | 2018 |
| Strategies to improve the response rate of thermosensitive PNIPAAm hydrogels XZ Zhang, XD Xu, SX Cheng, RX Zhuo Soft Matter 4 (3), 385-391, 2008 | 181 | 2008 |
| Multifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapy X Xu, J Wu, Y Liu, PE Saw, W Tao, M Yu, H Zope, M Si, A Victorious, ... ACS nano 11 (3), 2618-2627, 2017 | 179 | 2017 |
| Fabrication of supramolecular hydrogels for drug delivery and stem cell encapsulation DQ Wu, T Wang, B Lu, XD Xu, SX Cheng, XJ Jiang, XZ Zhang, RX Zhuo Langmuir 24 (18), 10306-10312, 2008 | 165 | 2008 |
| Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo WH Chen, XD Xu, HZ Jia, Q Lei, GF Luo, SX Cheng, RX Zhuo, XZ Zhang Biomaterials 34 (34), 8798-8807, 2013 | 149 | 2013 |
| Synthesis and properties of pH and temperature sensitive P (NIPAAm-co-DMAEMA) hydrogels B Wang, XD Xu, ZC Wang, SX Cheng, XZ Zhang, RX Zhuo Colloids and Surfaces B: Biointerfaces 64 (1), 34-41, 2008 | 147 | 2008 |
| Tumor microenvironment-responsive multistaged nanoplatform for systemic RNAi and cancer therapy X Xu, PE Saw, W Tao, Y Li, X Ji, M Yu, M Mahmoudi, J Rasmussen, ... Nano letters 17 (7), 4427-4435, 2017 | 121 | 2017 |
| Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release DQ Wu, YX Sun, XD Xu, SX Cheng, XZ Zhang, RX Zhuo Biomacromolecules 9 (4), 1155-1162, 2008 | 121 | 2008 |
| Low Molecular Weight Polyethylenimine Grafted N-Maleated Chitosan for Gene Delivery: Properties and In Vitro Transfection Studies B Lu, XD Xu, XZ Zhang, SX Cheng, RX Zhuo Biomacromolecules 9 (10), 2594-2600, 2008 | 119 | 2008 |
| Encapsulation of an adamantane-doxorubicin prodrug in pH-responsive polysaccharide capsules for controlled release GF Luo, XD Xu, J Zhang, J Yang, YH Gong, Q Lei, HZ Jia, C Li, RX Zhuo, ... ACS applied materials & interfaces 4 (10), 5317-5324, 2012 | 112 | 2012 |
| Non-coding RNAs: the new central dogma of cancer biology PE Saw, X Xu, J Chen, EW Song Science China Life sciences 64, 22-50, 2021 | 111 | 2021 |
| Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer Q Li, T Qin, Z Bi, H Hong, L Ding, J Chen, W Wu, X Lin, W Fu, F Zheng, ... Nature communications 11 (1), 1456, 2020 | 111 | 2020 |
| Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy Y Nie, H Huang, M Guo, J Chen, W Wu, W Li, X Xu, X Lin, W Fu, Y Yao, ... Clinical Cancer Research 25 (13), 3873-3886, 2019 | 111 | 2019 |
| Design of a Cellular‐Uptake‐Shielding “Plug and Play” Template for Photo Controllable Drug Release W Xiao, WH Chen, XD Xu, C Li, J Zhang, RX Zhuo, XZ Zhang Advanced Materials 23 (31), 3526-3530, 2011 | 107 | 2011 |
